Arcutis Biotherapeutics Inc (ARQT)
9.43
+0.17
(+1.84%)
USD |
NASDAQ |
Nov 18, 16:00
9.45
+0.02
(+0.21%)
After-Hours: 20:00
Arcutis Biotherapeutics Price to Book Value: 7.046 for Nov. 18, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 18, 2024 | 7.046 |
| November 15, 2024 | 6.919 |
| November 14, 2024 | 7.420 |
| November 13, 2024 | 7.823 |
| November 12, 2024 | 7.659 |
| November 11, 2024 | 8.100 |
| November 08, 2024 | 8.085 |
| November 07, 2024 | 7.771 |
| November 06, 2024 | 7.218 |
| November 05, 2024 | 6.949 |
| November 04, 2024 | 6.516 |
| November 01, 2024 | 6.478 |
| October 31, 2024 | 6.207 |
| October 30, 2024 | 6.364 |
| October 29, 2024 | 6.394 |
| October 28, 2024 | 6.506 |
| October 25, 2024 | 6.536 |
| October 24, 2024 | 6.282 |
| October 23, 2024 | 6.237 |
| October 22, 2024 | 6.229 |
| October 21, 2024 | 6.207 |
| October 18, 2024 | 6.513 |
| October 17, 2024 | 7.088 |
| October 16, 2024 | 7.260 |
| October 15, 2024 | 6.984 |
| Date | Value |
|---|---|
| October 14, 2024 | 7.275 |
| October 11, 2024 | 7.312 |
| October 10, 2024 | 7.305 |
| October 09, 2024 | 7.320 |
| October 08, 2024 | 7.230 |
| October 07, 2024 | 7.312 |
| October 04, 2024 | 7.484 |
| October 03, 2024 | 7.600 |
| October 02, 2024 | 7.641 |
| October 01, 2024 | 7.133 |
| September 30, 2024 | 6.946 |
| September 27, 2024 | 5.869 |
| September 26, 2024 | 5.743 |
| September 25, 2024 | 5.706 |
| September 24, 2024 | 6.069 |
| September 23, 2024 | 6.038 |
| September 20, 2024 | 6.364 |
| September 19, 2024 | 6.358 |
| September 18, 2024 | 6.521 |
| September 17, 2024 | 6.502 |
| September 16, 2024 | 6.370 |
| September 13, 2024 | 6.684 |
| September 12, 2024 | 6.596 |
| September 11, 2024 | 6.596 |
| September 10, 2024 | 6.816 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.076
Minimum
Dec 14 2021
14.46
Maximum
Mar 08 2024
4.910
Average
4.537
Median
Price to Book Value Benchmarks
| Mirum Pharmaceuticals Inc | 8.570 |
| Biogen Inc | 1.407 |
| Vertex Pharmaceuticals Inc | 7.694 |
| NovaBay Pharmaceuticals Inc | 3.207 |
| Palatin Technologies Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 7.744 |
| Price | 9.43 |
| Earnings Yield | -18.98% |
| Market Cap | 1.104B |